Detalles de la búsqueda
1.
Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.
Exerc Immunol Rev
; 26: 100-115, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32139351
2.
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma.
Oncotarget
; 11(4): 347-361, 2020 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064039
3.
Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.
Cancers (Basel)
; 12(5)2020 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354143
4.
Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Cancer Lett
; 371(2): 161-70, 2016 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655276
5.
Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology.
Oncolytic Virother
; 4: 149-55, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27512678
Resultados
1 -
5
de 5
1
Próxima >
>>